Reactions Weekly

, Volume 1658, Issue 1, pp 347–347 | Cite as

Nilotinib

Stroke and sudden death: 2 case reports
Case report
  • 20 Downloads

Reference

  1. Fossard G, et al. Hyperhomocysteinemia and high doses of nilotinib favor cardiovascular events in chronic phase Chronic Myelogenous Leukemia patients. Haematologica 101: e86-e90, No. 3, Jan 2016. Available from: URL: http://doi.org/10.3324/haematol.2015.135103 - FranceCrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations